Mark Klinger
- Immunology top 5%
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 9
- Immunotherapy and Immune Responses 7
- Immunodeficiency and Autoimmune Disorders 3
- Oncology top 5%
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 5
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 4
- Cancer Research top 10%
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 7
- Co-authors
- Malek FahamLawrence FongYafei HouEdward ChaCraig CummingsAntoni RibasRobert J. KayNigel Killeen
- Cited by
- ImmunologyOncologyHematology
- Journals
- The Journal of Immunology (4 papers)Journal of Clinical Oncology (4 papers)Blood (4 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Mark Klinger
30 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 79
- Immunology 872
- Oncology 696
- Hematology 274
- Cancer Research 200
- Genetics 127
Countries citing papers authored by Mark Klinger
This map shows the geographic impact of Mark Klinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Klinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Klinger more than expected).
Fields of papers citing papers by Mark Klinger
This network shows the impact of papers produced by Mark Klinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Klinger. The network helps show where Mark Klinger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Klinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2017 | 287 | |
| 3 | 2016 | 173 | |
| 4 | 2016 | 3 | |
| 5 | 2015 | 15 | |
| 6 | 2015 | 74 | |
| 7 | 2015 | 40 | |
| 8 | 2014 | 101 | |
| 9 | 2013 | 29 | |
| 10 | 2013 | 47 | |
| 11 | 2013 | 1 | |
| 12 | 2010 | 8 | |
| 13 | 2010 | 15 | |
| 14 | 2009 | 57 | |
| 15 | 2009 | 46 | |
| 16 | 2004 | 33 | |
| 17 | 2004 | 5 | |
| 18 | 2003 | 26 | |
| 19 | 2001 | 96 | |
| 20 | 2000 | 63 |
About Mark Klinger
Mark Klinger is a scholar working on Immunology, Genetics and Hematology, having authored 30 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (9 papers), Chronic Lymphocytic Leukemia Research (7 papers), Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Immunology (872 citations), Oncology (696 citations) and Hematology (274 citations). Mark Klinger has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Malek Faham, Lawrence Fong, Yafei Hou, Edward Cha, Craig Cummings, Antoni Ribas, Robert J. Kay, Nigel Killeen, Jianbiao Zheng and Harlan Robins. Their work appears in journals such as The Journal of Immunology, Journal of Clinical Oncology, Blood, Oncogene and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.